Cargando…
Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors—Results of Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey
SIMPLE SUMMARY: The aim of this survey of long-term survivors (LTS) with ovarian cancer was to enhance the knowledge on the patient characteristics and health concerns of this growing patient cohort in order to tailor follow-up care. Follow-up care is usually carried out within the first five years...
Autores principales: | Woopen, Hannah, Keller, Maren, Zocholl, Dario, Mittelstadt, Suzana, Barretina-Ginesta, Maria-Pilar, Heinzelmann-Schwarz, Viola, Lafleur, Judith, Kocián, Roman, Baum, Joanna, Krabisch, Petra, Achimas-Cadariu, Patriciu, Vardar, Mehmet Ali, Vergote, Ignace, Nasser, Sara, Link, Theresa, Gil-Martin, Marta, Zwimpfer, Tibor A., Leitner, Katharina, Jedryka, Marcin, Boxler, Tamara, Braicu, Elena Ioana, Sehouli, Jalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670049/ https://www.ncbi.nlm.nih.gov/pubmed/38001688 http://dx.doi.org/10.3390/cancers15225428 |
Ejemplares similares
-
DNA damaging agents in ovarian cancer
por: Barretina-Ginesta, Maria-Pilar
Publicado: (2020) -
Rare ovarian tumours. Other treatments for ovarian cancer
por: Gil-Martin, Marta, et al.
Publicado: (2020) -
S S Hanna Symposium
Publicado: (1991) -
Bevacizumab Combined with Platinum–Taxane Chemotherapy as First-Line Treatment for Advanced Ovarian Cancer: Results of the NOGGO Non-Interventional Study (OTILIA) in 824 Patients
por: Sehouli, Jalid, et al.
Publicado: (2021) -
Current Treatment Practices and Prognostic Factors in Early-Stage Ovarian Cancer—An Analysis of the NOGGO/JAGO
por: Heublein, Sabine, et al.
Publicado: (2023)